|
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2007). Relazione annuale 2007 : evoluzione del fenomeno della droga in Europa. Relazione annuale. Lussemburgo: Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
Observatoire européen des drogues et des toxicomanies. (2007). Rapport annuel 2007 : état du phénomène de la drogue en Europe. Rapport annuel. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2007). Annual report 2007 : the state of the drugs problem in Europe. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; Europe; annual report
|
|
|
|
Hibell, B., Guttormsson, U., Ahlström, S., Balakireva, O., Bjarnason, T., Kokkevi, A., et al. (2012). The 2011 ESPAD Report : substance use among students in 36 European countries. Stockholm: Swedish Council for Information on alcohol and Other Drugs (CAN).
Abstract: The European School Survey Project on alcohol and Other Drugs (ESPAD) is a collaborative effort of independent research teams in more than forty European countries, making it the largest cross-national research project on adolescent substance use in the world. ESPAD was founded in 1993, on the initiative of the Swedish Council for Information on alcohol and Other Drugs (CAN) and with the support of the Pompidou Group at the Council of Europe. In later years, ESPAD has also established co-operation with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), a body of the European Union. Most of the European continent is now covered by ESPAD, meaning that it provides a reliable overview of trends in substance use among 15-16-year-old European students. Data are collected every four years. This report presents the results from the fifth wave, conducted in 36 countries during spring 2011. It gives a comprehensive picture of the present situation among European young people as regards the use of tobacco, alcohol, cannabis and other substances, as well as an overview of trends in 1995-2011.
Keywords: AOD use; drug consumption; tobacco product; cannabis; smoking; illicit drug; drug user; adolescent; student; gender; survey; statistical data; incidence; Europe
|
|
|
|
Infodrog (Ed.). (2018). Complémentarité entre entraide et aide professionnalisée dans les addictions : une publication d'Infodrog. Berne: Infodrog, Centrale nationale de coordination des addictions.
Keywords: addiction care; professional counseling; self-help; cooperation; addiction mutual help and support group; self-management; e-health
|
|
|
|
Infodrog (Ed.). (2018). Kooperation zwischen Selbsthilfe und Suchthilfe : eine Publikation von Infodrog. Bern: Infodrog, Schweizerische Koordinations- und Fachstelle Sucht.
Keywords: addiction care; professional counseling; self-help; cooperation; addiction mutual help and support group; self-management; e-health
|
|
|
|
Infodrog (Ed.). (2014). Il lavoro con i pari nell’ambito delle dipendenze in Svizzera : raccomandazioni. Berna: Infodrog, Centrale nazionale di coordinamento delle dipendenze.
Keywords: peer prevention; peer education; recreational drug use; harm reduction; tertiary prevention; health promotion; treatment; brochure
|
|
|
|
Infodrog (Ed.). (2014). Travail avec les pairs dans le domaine des addictions en Suisse : recommandations. Berne: Infodrog, Centrale nationale de coordination des addictions.
Keywords: peer prevention; peer education; recreational drug use; harm reduction; tertiary prevention; health promotion; treatment; brochure
|
|
|
|
Infodrog (Ed.). (2014). Arbeit mit Peers im Suchtbereich in der Schweiz : ein Leitfaden. Bern: Infodrog, Schweizerische Koordinations- und Fachstelle Sucht.
Keywords: peer prevention; peer education; recreational drug use; harm reduction; tertiary prevention; health promotion; treatment
|
|
|
|
Menzi, P., Bernhardt Keller, A., Monterrubio Leu, C., & Galgano, M. L. (2010). Hepatitis C : manual prevention and therapy. Berne: Infodrog.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
